DUBLIN, Mar. 06, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/dgmfnn/omega3) has announced the addition of the "Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview" report to their offering.
Pharmaceutical drugs, by default, have started incorporating higher concentrations of omega-3 and it is anticipated that, over the coming few years, several new companies would be jumping on to the bandwagon of omega-3 drugs. Several drugs are in Phase II or Phase III clinical trials, with several more expected to come on-stream quite soon. However, the coming year or two is likely to witness an influx of new companies invading the global omega-3 market, provided they obtain the USFDA's or other relevant authorities' approvals.
In a global scenario where increasing attention is being directed towards issues of sustainability and limited food supplies, algal sources offer immense scope for the rapidly expanding omega-3 market to continue in the same vein. The focus on obtaining EPA and DHA from algae was prompted by an endeavor to seek out more sustainable sources, since EPA and DHA are naturally contained in algae. Moreover, the omega-3 content in fish and krill originates from their consuming the algae directly or other creatures that feed on algae. In addition to being sustainable, algae also allows for farming that can be of help in putting up desirable labels, such as vegetarian, kosher or even organic.
The past several decades have been witness to research studies that have underscored the significance of omega-3 fatty acids in maintaining heart health, in addition to safeguarding against cancer and birth defects and offsetting symptoms of diabetes, arthritis, cognitive decline, depression and several other conditions. Omega-3 Polyunsaturated Fatty Acids (PUFAs) have been growing and continues to grow significantly in the future, attributed to the above benefits.
Key Topics Covered:
TABLE OF CONTENTS:
PART A: GLOBAL MARKET PERSPECTIVE
2. GLOBAL REGULATORY LANDSCAPE FOR OMEGA-3 FATTY ACIDS
3. KEY MARKET TRENDS
4. INDUSTRY STRUCTURE AND COMPETETIVE LANDSCAPE
5. KEY GLOBAL PLAYERS
6. KEY BUSINESS TRENDS
7. KEY PRODUCT/TECHNOLOGY TRENDS
8. GLOBAL MARKET OVERVIEW
PART B: REGIONAL MARKET PERSPECTIVE
- REGIONAL MARKET OVERVIEW
- NORTH AMERICA
- REST OF WORLD
PART C: OMEGA-3 PATENT LANDSCAPE
PART D: GUIDE TO THE INDUSTRY
PART E: ANNEXURE
- Acasti Pharma Inc.
- Aker Biomarine AS
- Algae Biosciences Corporation
- Aurora Algae, Inc.
- Austral Group S.A.A.
- Ayanda AS
- BASF AS
- BASF Pharma (Callanish) Limited
- BASF SE
- BTSA Biotecnologías Aplicadas S.L
- Berg Lipidtech As (BLT)
- Cellana Inc.
- Chemport, Inc.
- Croda International Plc
- Cyvex Nutrition, Inc.
- Denomega Pure Health
- EPAX AS
- Enzymotec Ltd.
- Felda IFFCO LLC
- GC Rieber Oils
- Golden Omega SA
- Guangdong Runke Bioengineering Co Ltd
- Huatai Biopharm Inc.
- Hubei Fuxing Biotechnology Co Ltd
- InCon Processing LLC
- Jiangsu Auqi Marine Biotechnology Co., Ltd.
- KD-Pharma GmbH
- LYSI hf.
- Lonza Group Ltd
- Marine Ingredients
- Maruha Nichiro Foods Inc.
- Neptune Technologies & Bioressources Inc.
- Nippon Suisan Kaisha, Ltd. (Nissui)
- Olvea Fish Oils (Olvea Group)
- Omega Protein Corp.
- Pharma Marine AS
- Polaris Nutritional Lipids
- Pronova BioPharma ASA
- Qualitas Health Inc
- Royal DSM NV
- Seven Seas Ltd
- Sinomega Biotech Engineering Co Ltd
- Smit Functional Oils (Smit & Zoon Group)
- Solutex GC, S.L.
- Source-Omega LLC
- Stepan Company
- TASA Omega SA (Tecnológica De Alimentos SA)
- Zhejiang Shenzhou Marine Bio-Tech Co Ltd
For more information visit http://www.researchandmarkets.com/research/dgmfnn/omega3
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets